MICHELLE PROWANT: Open Payments
NPI 1982221057 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,508 in 64 payments from 25 companies in 2025. Trend: 2023 $578 · 2024 $926 · 2025 $1,508
Food & beverage: $1,338Education: $171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $263 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| ABBVIE INC. | 5 | $137 |
| Lilly USA, LLC | 2 | $133 |
| Incyte Corporation | 6 | $129 |
| Janssen Biotech, Inc. | 6 | $115 |
| Merck Sharp & Dohme LLC | 4 | $69 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Aveo Pharmaceuticals, Inc. | 2 | $47 |
| Stemline Therapeutics Inc. | 2 | $38 |
Products named: LYNPARZA, MONJUVI, KEYTRUDA, EPKINLY, ENHERTU, IMBRUVICA, DATROWAY, JAKAFI.
Industry payments across OH — which companies pay providers there.
